학술논문

The sodium glucose co-transporter 2 inhibitor dapagliflozin ameliorates the fluid-retaining effect of the endothelin A receptor antagonist zibotentan
Document Type
Article
Source
In: Nephrology Dialysis Transplantation. (Nephrology Dialysis Transplantation, 1 October 2023, 38(10):2289-2297)
Subject
Language
English
ISSN
14602385
09310509